Tag: SI-Bone
SI-Bone announces FDA clearance for expanded rod compatibility with the iFuse...
SI-Bone has announced additional US Food and Drug Administration (FDA) clearance for its iFuse Bedrock Granite, including new indications with a wide variety of...
SI-Bone receives FDA 510(k) clearance for iFuse Bedrock Granite
SI-Bone has announced that it has received US Food and Drug Administration (FDA) 510(k) premarket clearance for its iFuse Bedrock Granite implant system (Granite)—which...
Majority of women unaware that SI joint issues a leading cause...
Results of a recent survey of 1,000 women (age 35–60) conducted by SI-Bone found that 86% of respondents are unaware that sacroiliac (SI) joint...
SI-Bone announces publication of two-year iMIA randomised controlled trial results
Two-year results of a randomised controlled trial, published in the Journal of Bone and Joint Surgery, suggest that minimally invasive sacroiliac joint arthrodesis with triangular...
“Significantly more bone infiltration” with 3D-printed triangular sacroiliac joint fusion implants
The popularity of sacroiliac joint fusion has grown rapidly over the past five years, with SI-Bone’s Ifuse device leading the market. Recently approved by...
One-year data reveal superior pain improvements for SI-Bone Ifuse
One-year results from the IMIA (Ifuse Implant System Minimally Invasive Arthrodesis) randomised controlled trial have shown better pain and disability improvements for SI-Bone’s Ifuse...
SI-Bone launches new 3D-printed porous Ifuse-3D sacroiliac joint fusion device
SI-Bone has launched its new Ifuse-3D implant in the USA following regulatory clearance by the US Food and Drug Administration. The new titanium device...
US military’s Tricare health care programme offers minimally invasive sacroiliac joint...
Tricare has established a written coverage policy for minimally invasive sacroiliac joint fusion surgery. Tricare is a regionally-managed US healthcare programme for active duty...
Si-Bone Ifuse sacroiliac joint fusion procedure reaches 25,000 milestone
The Si-Bone Ifuse minimally invasive sacroiliac joint fusion implant system has been used in more than 25,000 procedures worldwide, according to a company release....
Six-year positive results published on Si-Bone iFuse
Si-Bone has announced the publication of a six-year study comparing the company’s Ifuse implant to both conservative management and radiofrequency denervation. The long-term study...
Decortication and bone-grafting may “contribute to earlier fusion” following sacroiliac joint...
Sacroiliac joint fusion has progressed markedly over the past five years. Positive results—the majority involving SI-Bone’s Ifuse device—have been reported in a growing number...
Sacroiliac joint fixation with screws leads to more revision than fusion...
A single-centre retrospective study of patients who had undergone sacroiliac joint fusion has compared revision rates between those who received fusion via titanium triangular...
SI-Bone submits INSITE data to Yale University Open Data Access programme
SI-Bone has submitted INSITE (Investigation of Sacroiliac Fusion Treatment) two-year randomised controlled trial data to Yale University's Open Data Access (YODA) programme.
INSITE is a...
Two-year INSITE results show positive outcomes for SI-Bone iFuse system
SI-Bone has announced the publication of two-year results from INSITE (Investigation of Sacroiliac Fusion Treatment) a landmark prospective, multicentre, randomised controlled trial of minimally...
Investigating sacroiliac joint fusion surgery
Sacroiliac joint fusion surgery has grown in popularity over the past five years. Whilst procedure rates are still relatively low, many physicians are convinced...